Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps2-13-09 | Surgery | ETA2023

Body mass index and postoperative morbidity after thyroid surgery: findings from a large retrospective cohort study

Lazzari Giovanni , Di Filippo Giacomo , Morelli Eleonora , Serbusca Dorin , Marino Nicola , Dall'Oco Isabella , Brazzarola Paolo

Background: Obesity is a major public health issue frequently associated with increased complication rates after elective general surgery. Previous reports on complications after thyroid surgery in obese patients were performed on selected cohorts. In this study, we sought to explore the relationship between Body Mass Index (BMI) and postoperative morbidity after thyroid surgery in a large cohort of consecutive patients.Materials and Methods: A single-ce...

ea0092ps1-04-04 | Nodules-surgery | ETA2023

Volume reduction rate’s predictors after radiofrequency ablation of benign thyroid nodules. a single-centre analysis

Di Filippo Giacomo , El Dalati Ghassan , Lazzari Giovanni , Morelli Eleonora , Serbusca Dorin , Gobbo Giulia , Odorizzi Ylenia , Brazzarola Paolo

Background: Ultrasound guided minimally invasive therapies are becoming increasingly popular for the treatment of symptomatic benign thyroid nodules. Efforts have been directed on the prediction of volume reduction as a measure of efficacy of the procedure. Aim of the present study is to identify predictors of 6-months volume reduction rate (VRR) after radiofrequency ablation of benign thyroid nodules.Materials and Methods: We performed a retrospective s...

ea0037oc3.1 | Calcium, vitamin D and bone | ECE2015

Effect of GNAS transcript manipulation on human mesenchymal stem cells differentiation towards osteocyte cell lineage: insight into the pathophysiology of ectopic ossification in GNAS-related disorders

Elli Francesca Marta , Boldrin Valentina , Parazzi Valentina , Ragni Enrico , Bordogna Paolo , Spada Anna , Lazzari Lorenza , Mantovani Giovanna

Epi/genetic defects at the imprinted GNAS locus, that encodes the α subunit of the stimulatory G protein (Gsα), have been associated with a heterogeneous group of rare diseases, termed as Pseudohypoparathyroidism. Most GNAS-based disorders have the common feature of episodic de novo formation of heterotopic ossifications (HO) in subcutaneous tissues. The mosaic tissue distribution of HO suggests that pathogenesis involves an abnormal differentiation of precu...

ea0063s14.3 | Innovations in NETs | ECE2019

Fishing for NETs

Vitale Giovanni

Neuroendocrine tumors (NETs) are a class of rare and heterogeneous neoplasms derived from the neuroendocrine system. Animal models are indispensable tools for investigating the pathogenesis, mechanisms for tumour invasion and metastasis and new therapeutic approaches for cancer. Unfortunately, only few models are available for NETs, probably due to the rarity and heterogeneity of this group of neoplasms. The tropical teleost zebrafish (Danio rerio) is a popular vertebrate mode...

ea0063s22.2 | The pituitary as metabolic sensor (Endorsed by Endocrine Connections) | ECE2019

How treatments with endocrine & metabolic drugs influence pituitary cell function?

Tulipano Giovanni

A variety of endocrine and metabolic signals regulate pituitary cell function acting through the hypothalamus-pituitary neuroendocrine axes or directly at the pituitary level. The underlying intracellular transduction mechanisms in pituitary cells are still debated. AMP-activated protein kinase (AMPK) functions as a cellular sensor of low energy stores in all mammalian cells and promotes adaptive changes in response to calorie restriction. It is also regarded as a target for t...

ea0056s9.3 | EAA /ESE Session: Male gonadal function versus general health and vice versa | ECE2018

Does ‘healthy obesity’ exist in andrology?

Corona Giovanni

Introduction: Obesity is a cause of erectile dysfunction (ED) whereas its relationship with male infertility is more conflicting. The term metabolically healthy obesity (HO) has been used to describe an obese phenotype that does not have the burden of any metabolic disorder. The aim of the present study is to analyse the contribution of HO in the pathogenesis of ED and male infertility and to verify the value of HO in predicting major adverse cardiovascular events (MACE).<...

ea0056s20.2 | All you need to know about lipodystrophy (Endorsed by Endocrine Connections) | ECE2018

Acquired forms of lipodystrophy

Ceccarini Giovanni

Acquired lipodystrophies (AL) are syndromes characterized by an irreversible loss of subcutaneous adipose tissue and are conventionally distinct in partial (Barraquer-Simons) or generalized forms (Lawrence Syndrome) based on the pattern of adipose tissue disappearance. Alike to congenital forms, AL exhibit metabolic abnormalities that include insulin resistance, diabetes mellitus, hypertliglycerdidemia, reduced leptin levels, hepatomegaly and steatosis. While in most cases of ...

ea0063p244 | Pituitary and Neuroendocrinology 1 | ECE2019

Effects of octreotide on hallmarks of autophagy and on parameters related to cell viability and metabolic activity in rat pituitary tumor cells

Tulipano Giovanni , Giustina Andrea

We investigated the direct effects of the somatostatin analog octreotide on hallmarks of autophagy and of cell viability and metabolic activity in rat pituitary tumor cells (GH1 and GH3 cells). The Western blot analysis of cell lysates suggested that octreotide (100 nM) treatment could induce changes in hallmarks related to autophagy activation (increased LC3-I protein lipidation) and to enhanced autophagic flux (SQSTM1/p62 protein downregulation) in pituitary tumor cells in d...

ea0032pl2 | NET Management | ECE2013

Neuroendocrine tumour management

Bodei Lisa , Paganelli Giovanni

Neuroendocrine tumours (NETs) tend to be slow growing (although aggressive forms exist) and are often diagnosed when they have already metastasised.Treatment of NETs is typically multidisciplinary and should be individualised according to the tumour type, burden, and symptoms. Therapeutic tools in NETs include surgery, interventional radiology and medical treatments such as somatostatin analogues, interferon, chemotherapy, new targeted drugs and peptide ...

ea0011p528 | Endocrine tumours and neoplasia | ECE2006

Characterization of familial non-syndromic pheochromocytoma

Opocher G , Schiavi F , Iacobone M , Sattarova S , Erlic Z , Martella M , Mian C , Zambonin L , De Lazzari P , Murgia A , Favia G , Mantero F

Hereditable forms account for 30–40% of pheochromocytomas (pheo). The role of germ-line mutation of VHL, RET, SDHB, SDHD gene has been largely elucidated. However, genotyping a group of 172 sporadic or familial pheo, we have characterize five unrelated probands with familial pheo without any sequence variants of RET (7 exons), or of the entire coding sequence of VHL, SDHB, SDHC or SDHD.The proband #1 had a bilateral pheo when 32 and a local recurren...